None
Conditions
Sponsors
APO PLUS STATION CO., LTD.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Japanese males between the ages of 20 and 60 years old at the time consent is obtained. 2) Persons with no abnormalities in blood glucose levels (no abnormalities in blood glucose levels ever indicated in a medical checkup) 3) BMI between 18.5 kg/m2 and 22.0 kg/m2 4) Persons who have received a full explanation of the purpose and content of the study and who have signed a consent form prior to the start of the study.
Exclusion criteria
Exclusion criteria: 1) Those who have a history or current condition (disease) of liver disease, renal disease, cerebrovascular disease, diabetes, dyslipidemia, hypertension, or other chronic diseases. 2) Those who are currently undergoing treatment for a serious illness. 3) Persons with food allergies or those who may develop allergies related to the tested food items. 4) Persons who regularly use medicines or quasi-drugs that may affect the test items. 5) Persons who regularly use health foods (food for specified health use, nutritional supplements, functional foods, supplements, etc.) that may affect the test items. 6) Those who are unable to discontinue the intake of pharmaceuticals (excluding intravenous medication), quasi-drugs, or health foods (food for specified health uses, nutritional supplements, foods with functional claims, supplements, etc.) from the time of obtaining consent to the completion of the study. 7)Who are currently participating in a clinical trial or have participated in another clinical trial within the past 3 months from the date of obtaining consent. 8) Those who plan to participate in other clinical trials during the study period. 9)Those whose daily life is extremely irregular. 10)Persons who have difficulty consuming the study food as instructed. 11) Other subjects who are judged by the investigator to be unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the blood glucose concentration curve AUC (pre-load to 180 min post ingestion) | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose level (at each blood collection point) | — |
Countries
Japan
Contacts
Public ContactMasako Mizuuchi
APO PLUS STATION CO., LTD. Clinical Operation Department, CRO Business Division
Outcome results
None listed